Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Hemasphere|July 1, 2024
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cellsGloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2023
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell TherapyGloria Iacoboni, Víctor Navarro, Ana África Martín-López, et al.
Blood|July 11, 2025
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletionClaire Roddie, Juliana Dias, Maeve O'Reilly, et al.
Leukemia|April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapyGloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2020
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, et al.
Cytotherapy|December 13, 2022
A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufactureMaeve A O'Reilly, Aman Malhi, Kathleen P L Cheok, et al.
Neonatology|November 7, 2024
Neonatal Outcomes following 2 Cases of Maternal CAR-T Therapy for High-Grade B-Cell LymphomaDaniel O'Reilly, Charlotte Jones, Aisling Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry studyAndrew D Chantry, John A Snowden, Charles Craddock, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2023
Large-scale manufacturing of base-edited chimeric antigen receptor T cellsRosie Woodruff, Farhaan Parekh, Katarina Lamb, et al.
Bone|April 29, 2006
Elevated serum FGF23 concentrations in plasma cell dyscrasiasInge Stewart, Claire Roddie, Anthony Gill, et al.
Pageof 9